Our experienced support team is ready and eager to help
Introduction to GLP-1s In the pursuit of better health, understanding how our body regulates appetite, blood sugar, and metabolism is crucial
In 2023, Juan P Frias and colleagues, in The Lancet, published the first phase two clinical trial of orforglipron, which investigated the use of a small-molecule oral GLP-1R agonist called orforglipron in type 2 diabetes, which can be taken at any time of the day without restrictions on food and water intake (Frias et al., 2023)
That makes it difficult to confirm that semaglutide directly caused the skin problem
It protects the neurons and may reduce age-related oxidative stress, which plays a role in the pathogenesis
When you take semaglutide, it mimics the action of GLP-1